Based on its role in promoting a less differentiated, more persistent memory phenotype, interleukin-15 would be predicted to enhance the functional capacity of CAR T cells, leading to increased release of effector cytokines (such as IFN-γ and TNF-α) upon antigen stimulation compared to CAR T cells manufactured without it.